Recent News

By Category: Research

U.S. Congress fails to pass WMD legislation – Examiner.com

Examiner.comU.S. Congress fails to pass WMD legislationExaminer.comCalling the legislation a "comprehensive approach to improving America's biodefense capabilities," WMD Commission Chair, Sen. Bob Graham, and Vice-Chair, …and more »

July 17, 2010
| Filed under North America and Research
Share

PharmAthene Presents New Data For Lyophilized RPA Anthrax Vaccine Showing Enhanced Immunogenicity

PharmAthene Inc., a biodefense company developing medical countermeasures against biological and chemical threats, announced results from a New Zealand White Rabbit study showing that its lyophilized recombinant Protective Antigen (rPA) anthrax vaccine was more immunogenic than a liquid formulation of rPA vaccine and produced a robust response with only 2 doses…

July 16, 2010
| Filed under North America and Research
Share

UTSA granted patent for vaccine research

University of Texas at San Antonio scientists have been granted a patient for developing a process to create a vaccine against a disease called tularemia. It’s an infectious agent that could be deadly in the hands of terrorists.

July 14, 2010
| Filed under North America and Research
Share

Wave Technology Studied For WMD Detection

Scientists in New York are preparing new detection technology that uses terahertz wave technology to “see through” apparel and packages that could be hiding biological or chemical weapons materials, United Press International reported Monday.

July 14, 2010
| Filed under North America, Biological Weapons, and Research
Share

Former Senators Criticize Possible Cut to Bioshield Funds

WASHINGTON — Leading bioterrorism experts yesterday criticized the Obama administration’s apparent willingness to support a measure that could strip $2 billion from the coffers of programs to develop WMD countermeasures and fight pandemic flu.